Primary peritoneal carcinoma

Primary peritoneal cancer or carcinoma is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma, psammomacarcinoma. It was historically classified under "carcinoma of unknown primary" (CUP). Primary peritoneal cancer (PPC, or PPCa)^[1] is a cancer of the cells lining the peritoneum, or abdominal cavity.

Prognosis and treatment is the same as for the most common type of ovarian cancer, which is epithelial ovarian cancer.^[2]^[3]

The median survival of primary peritoneal carcinomas is usually shorter by 2–6 months time when compared with serous ovarian cancer.

References

↑ Jaaback KS, Ludeman L, Clayton NL, Hirschowitz L (2006). "Primary peritoneal carcinoma in a UK cancer center: comparison with advanced ovarian carcinoma over a 5-year period". Int. J. Gynecol. Cancer. 16 (Suppl 1): 123–8. doi:10.1111/j.1525-1438.2006.00474.x. PMID 16515579. S2CID 2907689.
↑ "New Drug Combination for Ovarian and Primary Peritoneal Cancers - National Cancer Institute". Archived from the original on 2010-12-24. Retrieved 2018-01-23.
↑ "eMedicine — Peritoneal Cancer : Article by Wissam Bleibel". 15 July 2021.

This short article about medicine can be made longer. You can help Wikipedia by adding to it.

[pmid16515579-1] Jaaback KS, Ludeman L, Clayton NL, Hirschowitz L (2006). "Primary peritoneal carcinoma in a UK cancer center: comparison with advanced ovarian carcinoma over a 5-year period". Int. J. Gynecol. Cancer. 16 (Suppl 1): 123–8. doi:10.1111/j.1525-1438.2006.00474.x. PMID 16515579. S2CID 2907689.

[urlNew_Drug_Combination_for_Ovarian_and_Primary_Peritoneal_Cancers_-_National_Cancer_Institute-2] "New Drug Combination for Ovarian and Primary Peritoneal Cancers - National Cancer Institute". Archived from the original on 2010-12-24. Retrieved 2018-01-23.

[urleMedicine_—_Peritoneal_Cancer_:_Article_by_Wissam_Bleibel-3] "eMedicine — Peritoneal Cancer : Article by Wissam Bleibel". 15 July 2021.

[1]

[2]

[3]